The year 2022 has been marked by many new developments in the fields of heart failure and valvulopathy treatment. These advances will certainly improve our daily practice and the treatment of many patients. Key Words Heart failure with reduced ejection fraction, Heart failure with preserved ejection fraction, tricuspid valve regurgitation
Key Words
Heart failure with reduced ejection fraction, Heart failure with preserved ejection fraction, tricuspid valve regurgitation